A detailed history of Sectoral Asset Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Sectoral Asset Management Inc holds 4,410 shares of BPMC stock, worth $475,309. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,410
Previous 2,470 78.54%
Holding current value
$475,309
Previous $227,000 84.14%
% of portfolio
0.21%
Previous 0.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$73.17 - $99.79 $141,949 - $193,592
1,940 Added 78.54%
4,410 $418,000
Q4 2023

Feb 14, 2024

SELL
$43.96 - $92.84 $7.18 Million - $15.2 Million
-163,420 Reduced 98.51%
2,470 $227,000
Q3 2023

Nov 14, 2023

BUY
$46.9 - $66.0 $1.36 Million - $1.92 Million
29,053 Added 21.23%
165,890 $8.33 Million
Q2 2023

Aug 11, 2023

BUY
$42.2 - $66.37 $630,341 - $991,368
14,937 Added 12.25%
136,837 $8.65 Million
Q1 2023

May 12, 2023

BUY
$37.97 - $50.0 $227,820 - $300,000
6,000 Added 5.18%
121,900 $5.48 Million
Q4 2022

Feb 10, 2023

BUY
$41.06 - $66.48 $246,360 - $398,880
6,000 Added 5.46%
115,900 $5.08 Million
Q3 2022

Nov 10, 2022

BUY
$49.93 - $77.7 $1.4 Million - $2.18 Million
28,000 Added 34.19%
109,900 $7.24 Million
Q1 2022

May 10, 2022

BUY
$54.1 - $110.08 $871,010 - $1.77 Million
16,100 Added 24.47%
81,900 $5.23 Million
Q4 2021

Feb 11, 2022

BUY
$94.25 - $115.99 $6.2 Million - $7.63 Million
65,800 New
65,800 $7.05 Million
Q1 2021

May 14, 2021

SELL
$90.71 - $108.28 $12.4 Million - $14.8 Million
-136,500 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$92.08 - $124.48 $14.6 Million - $19.7 Million
-158,233 Reduced 53.69%
136,500 $15.3 Million
Q3 2020

Nov 13, 2020

BUY
$66.45 - $92.7 $275,767 - $384,705
4,150 Added 1.43%
294,733 $27.3 Million
Q2 2020

Aug 13, 2020

BUY
$57.09 - $79.27 $16.6 Million - $23 Million
290,583 New
290,583 $22.7 Million
Q1 2020

May 13, 2020

SELL
$48.11 - $82.22 $2.16 Million - $3.7 Million
-45,000 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$66.73 - $82.59 $3 Million - $3.72 Million
45,000 New
45,000 $3.61 Million
Q3 2019

Nov 14, 2019

SELL
$72.9 - $101.41 $800,733 - $1.11 Million
-10,984 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $500,072 - $665,040
6,800 Added 162.52%
10,984 $1.04 Million
Q3 2018

Nov 14, 2018

BUY
$58.91 - $78.32 $246,479 - $327,690
4,184 New
4,184 $327,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.44B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.